Legend Biotech Corp (LEGN) Corporate Subsidiaries
Legend Biotech Corp (LEGN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LEGN
CIK: 1801198
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerBrent Ashton
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-15 | 2026-10-15 | FORM 6-K | 0001171843-26-006646 | View SEC Doc Filr Page |
| 6-K | 2026-10-13 | 2026-10-13 | FORM 6-K | 0001171843-26-006593 | View SEC Doc Filr Page |
| S-8 | 2026-10-07 | — | FORM S-8 | 0001171843-26-006498 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-29 | 4 Filing | 0001796536-26-000010 | View SEC Doc Filr Page |
| 144 | 2026-09-29 | — | 144 Filing | 0001959173-26-007138 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | 4 Filing | 0002088468-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | 4 Filing | 0001814673-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | 4 Filing | 0002106809-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | 4 Filing | 0002068365-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | 4 Filing | 0001974687-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | 4 Filing | 0001796536-26-000009 | View SEC Doc Filr Page |
| 6-K | 2026-09-25 | 2026-09-24 | FORM 6-K | 0001171843-26-006229 | View SEC Doc Filr Page |
| 6-K | 2026-09-24 | 2026-09-24 | FORM 6-K | 0001171843-26-006215 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-21 | 4 Filing | 0002097065-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-09-22 | — | 144 Filing | 0001959173-26-007077 | View SEC Doc Filr Page |
| 144 | 2026-09-22 | — | 144 Filing | 0001959173-26-007076 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-15 | 4 Filing | 0001964342-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-09-16 | 2026-09-15 | 3 Filing | 0001964342-26-000003 | View SEC Doc Filr Page |
| 6-K | 2026-09-15 | 2026-09-15 | FORM 6-K | 0001171843-26-006050 | View SEC Doc Filr Page |
| 6-K | 2026-09-14 | 2026-09-14 | FORM 6-K | 0001171843-26-006027 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | 4 Filing | 0001908421-26-000005 | View SEC Doc Filr Page |
| 6-K | 2026-08-18 | 2026-08-18 | FORM 6-K | 0001171843-26-005623 | View SEC Doc Filr Page |
| 6-K | 2026-08-11 | 2026-06-30 | 6-K | 0001801198-26-000022 | View SEC Doc Filr Page |
| 6-K | 2026-08-06 | 2026-08-06 | FORM 6-K | 0001171843-26-005318 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002041 | View SEC Doc Filr Page |